Silence, Nouscom, Musixmatch — $1.3B for siRNA, €120M for cancer interception and music rights — Daily News October 19, 2026
About this episode
Merck KGaA signs the approximately $1.3 billion agreement for Silence Therapeutics, Nouscom raises €120 million, and Musixmatch acquires Music Reports.
Europe's most interesting startup stories. Every week.
No spam. Unsubscribe anytime.
Main news
Startups mentioned
Silence Therapeutics
A Nasdaq-listed London biotech designing liver-targeted siRNA medicines with its mRNAi GOLD platform; its lead candidate is divesiran for polycythemia vera.
Nouscom
A biotech headquartered in Basel with operations in Rome developing viral-vector immunotherapies against tumour neoantigens; its lead candidate is NOUS-209.
Musixmatch
Bologna startup founded by Max Ciociola that manages the world's largest lyrics database and supplies music data to Spotify, Amazon Music, Apple Music and other platforms.
Why they matter
Acquisire registri o finanziare piattaforme scientifiche aumenta il controllo sugli asset, senza eliminare il rischio di esecuzione.